[1]
Gerdzhikova, K. et al. 2022. Effectiveness and Safety of Treatment with Nucleo(s)tide Analogues in Patients with Hepatitis B-related Cirrhosis. Proceedings of the Bulgarian Academy of Sciences. 75, 7 (July 2022), 1063–1071. DOI:https://doi.org/10.7546/CRABS.2022.07.15.